Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
To minimize treatment interruptions due to adverse reactions, subsequent Phase III clinical trials may adopt a more gradual dose-escalation strategy to reduce the incidence and severity of gastrointestinal discomfort and other adverse events, thereby enhancing patient tolerance and adherence to the medication
However, patients should be careful with this claim
Comparison of lanosterol-14 alpha-demethylase (CYP51) of human and Candida albicans for inhibition by different antifungal azoles
This decline from 200 ng/mL to 80 ng/mL correlates directly with decreased regenerative capacity and visible signs of aging
Mast Cells: When the Immune System Overreacts Chronic exposure can push mast cells into hyper-reactivity, releasing histamine, prostaglandins, and cytokines that drive inflammation and autoimmunity [33]
References Jalleh RJ, Plummer MP, Marathe CS, Umapathysivam MM, Quast DR, Rayner CK, Jones KL, Wu T, Horowitz M, Nauck MA
